New Era in Atopic Dermatitis Treatment: Results of Long-Term Dupilumab Administration
Atopic dermatitis (AD) is a disease characterized by chronic skin inflammation and epidermal barrier dysfunction leading to decrease in patients' quality of life. AD is widespread in general population including children. This article covers the disease pathophysiological mechanisms including t...
Saved in:
| Main Authors: | Nikolay N. Murashkin, Leonid A. Opryatin, Roman V. Epishev, Alexander I. Materikin, Eduard T. Ambarchyan, Roman A. Ivanov, Dmitriy V. Fedorov, Daria S. Kukoleva |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
"Paediatrician" Publishers LLC
2021-11-01
|
| Series: | Вопросы современной педиатрии |
| Subjects: | |
| Online Access: | https://vsp.spr-journal.ru/jour/article/view/2757 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biologic Therapy of Moderate and Severe Forms of Atopic Dermatitis in Children
by: Nikolay N. Murashkin, et al.
Published: (2020-12-01) -
Dupilumab Efficacy and Safety in Severe Atopic Dermatitis in Children under 6 Years of Age: Two Clinical Cases
by: Nikolay N. Murashkin, et al.
Published: (2023-11-01) -
Newborn Skin Care is the Basis for Prevention of Atopic Dermatitis Development
by: Nikolay N. Murashkin, et al.
Published: (2021-11-01) -
Dupilumab Efficacy in Children with Palmoplantar Eczema
by: Nikolay N. Murashkin, et al.
Published: (2024-11-01) -
Pruritus and Atopic Dermatitis: from Etiological Features to Management
by: Nikolay N. Murashkin, et al.
Published: (2020-12-01)